chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; Information has been received from a lawyer regarding a case in litigation concerning a currently 57-year-old female patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed zoster vaccine live (ZOSTAVAX) by a healthcare provided for the long-term prevention of shingles and zoster-related conditions. In 2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) by a healthcare provider. On an unknown date, the patient was treated by a healthcare provider for the following injuries resulting from the use of zoster vaccine live (ZOSTAVAX): shingles. The outcome of the event was not reported. The reporter felt the event was related to the suspect vaccine.
Saturday 2 hours after shot severe nausea. Saturday night tingling in arms,hands, leg,feet. Severe headache that has not gone away. Headed to Urgent Care Monday morning the 15th.
Sore arm evening of first shot. Aching hips and shoulders two days after first shot.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2012, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) for prophylaxis. On an unknown date, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. In 2014, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
Extreme shoulder pain from the moment of the booster shot to the present (1/28/22); The ongoing pain from this incident has restricted my weight-lifting regime which I use to maintain my health and strength; It disrupted my sleep each night and limited my daily activities; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 06Oct2021 (Lot number: FF8841, Expiration Date: 29Oct2021) at the age of 74 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), administered in arm left, administration date 06Oct2021 (Batch/Lot number: unknown) as dose number unknown, single. Relevant medical history included: "Weakened immune system" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Route of administration: Intramuscular), administration date: 30Jan2021, for COVID-19 immunization, reaction(s): "arm pain"; Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6203, Location of injection: Arm Left, Route of administration: Intramuscular), administration date: 20Feb2021, for COVID-19 immunization, reaction(s): "arm pain". The following information was reported: ARTHRALGIA (non-serious) with onset 06Oct2021, outcome "not recovered", described as "Extreme shoulder pain from the moment of the booster shot to the present (1/28/22)"; ASTHENIA (non-serious) with onset 06Oct2021, outcome "recovering", described as "The ongoing pain from this incident has restricted my weight-lifting regime which I use to maintain my health and strength"; SLEEP DISORDER (non-serious) with onset 06Oct2021, outcome "recovering", described as "It disrupted my sleep each night and limited my daily activities". The events "extreme shoulder pain from the moment of the booster shot to the present (1/28/22)", "the ongoing pain from this incident has restricted my weight-lifting regime which i use to maintain my health and strength" and "it disrupted my sleep each night and limited my daily activities" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, asthenia, sleep disorder.  Additional Information: As I write this 10Feb2022 it is getting better. I have not lifted for 2 weeks, so I Thank you for your follow-up on this matter. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, has not been diagnosed with Covid-19 prior to vaccination and has not been tested for COVID-19 Since the vaccination. No adverse event from the first two shots. Whereas arm pain from the first two shots was not felt until later that day and went away in a couple of days, the pain from the booster was immediate and severe.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from physician's assistant via field employee regarding an 17 years old male patient (age reported as 17 years at the time of vaccination). There was no information on patient's medical history and drug reactions or allergies. On 20-APR-2012, the patient was vaccinated with GARDASIL intramuscular injection single standard dose intramuscularly taken intramuscularly. There was no concomitant medications. On 20-APR-2012, the patient fainted after his first dose with GARDASIL (disability) (reported as significant disability or incapacity: "syncope"). The patient decided not to continue with the series with GARDASIL after having this reaction. The lab diagnostics studies performed was unknown. No treatment was given. The patient did not seek any medical attention. There was no product quality complaint involved. On an unknown date the patient recovered from the event. The causality of the event with GARDASIL was unknown. Additional information has been requested.
Reported chills around 7:30 pm on December 10, 2021.  Fever of 102.7 degrees fahrenheit  taken with the  Braun No Touch + Forehead Thermometer on the same day around 10:00 pm.  Gave two ibuprofen 200 mg gel caps at 10:30 pm. reported he still had cold chills
Information has been received from a physician concerning a 14 year old female with drug hypersensitivity to PANCOF and with no known pertinent medical history who on 23-APR-2008 was vaccinated with a first and only dose of GARDASIL vaccine IM (lot# 654272/0073X). Concomitant therapy included MENACTRA. The patient developed mastitis after receiving GARDASIL vaccine. A sonogram was performed. The patient was treated with an antibiotic (unspecified). The patient was recovering. The patient sought medical attention by seeing the physician. Additional information has been requested.
After Client completed the 15 minute observation period ,upon standing he complained of rapid heart rate.  Client was then monitored for an additional 30 minutes 3:06 pm  BP -160 /80  HR -120, O2 sat 99%         3;21pm  Bp- 140/80 ; HR 120 O2 saturation 99%  Client stated he was feeling better 3;36pm Bp _ 132/80  HR - 80 ,  O2  sat 99% CLient stated he was feeling better   was allowed to leave with step son  and wife. Client was advised to rest and seeking medical attention should symptoms reoccur.
Patient had a skin reaction possibly from covid vaccine. The following day developed shortness of breath and was sent to the ER
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was respiratory failure with hypoxia due to COVID-19 infection.
0815 144/73, 99% O2. RR 20, HR 65/min. Patient then started to experience mid sternal non radiating chest "tightness" 3/10. States she experienced the same sensation after first vaccine. Prior experience started after discharge and lasted 3-4 hours , evenChills: Status post emergency room evaluation for atypical chest pain after her second Covid vaccination. No further symptoms. Work-up unremarkable.
Developed parotid enlargement with multiple sicca symptoms, digestive symptoms including constipation. No improvement on same until placed on prednisone some 6 months later, with recurrence of symptoms as prednisone was tapered.
I21.4 ACUTE NON ST ELEVATION MI 5/1/2023 SYNCOPE I21.4 ACUTE NON ST ELEVATION MI 5/1/2023 ACUTE NON ST ELEVATION MI
Silver dollar sized welt at injection site on day 8 (4/8/21). Initial irritation began to clear and then on day 14 (4/14/21) atopic dermatitis (rash) appeared above injection site over to shoulder. On day 17 (4/17/21), rash spread to left side of neck and chest.  Sought medical attention on day 16 and received Rx for steroid ointment.
sore injection site the next day, next day at 10am began experiencing aches in my joints and achey muscles all over, mild headache, fatigue. At around 1pm experienced chills and fever. Experienced 3 episodes of diarrhea that started about 5 hours after the vaccine.
nauseous; chest hurts; body hurts; still feeling very ill; Not been able to keep food down; This is a spontaneous report from a contactable consumer (Patient) received from a Pfizer Sponsored Programme COVAX Support. A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number & expiry date note reported) via unspecified route of administration on 28Mar2021 as dose 2, single for COVID-19 Immunisation. Patient medical history and concomitant medications were not reported. Caller received the second dose of the Covid vaccine 4 days ago. There are very severe side effects she reported. On unspecified date, reported as she has not been able to keep food down. She is very nauseous. Her chest hurts, feels like it is caving in. Her body hurts and over all report everything else hurts. After the vaccine patient was still feeling very ill. Caller enquired if this is normal. She enquired what to do about the side effects and how long do they last. Lot number was not available as limited information was available over the call. The Outcome of all Events was unknown   No follow-up attempts are possible; information about lot/batch cannot be obtained.
Client called the clinic this morning stating "a couple of hours after getting Tdap and Hepatitis A vaccines, I felt nauseous and started having diarrhea. I looked it up and think it is from the shots. Work told me to call you. I feel fine otherwise." Client denies fever but states her arm "really hurts." This nurse suggested she eat bananas, rice, applesauce and toast. Also, she could put a cool washcloth on her arm for the arm pain. This nurse told her if the nausea and diarrhea don't go away after a few days, she should see a doctor. Client voiced understanding.
Headache onset within 30 min, malaise within 90 min; 2nd day onset of flu-like symptoms (headache, fatigue, painful joints, mild dizziness).  Headache and joint pain lasted 4 days.
7 days post first dose, injection site is inflamed, red and hot to the touch, radiating out from the injection site. Other symptoms are: headache, fatigue, nausea and 'feeling hot'. No fever at this time.
Felt fine at first, but then suffered flu-like symptoms including extreme fatigue, stomach discomfort, gas, nausea, loss of appetite, acid reflux. Some symptoms have ceased or lessened, but extreme fatigue, lack of appetite and some stomach discomfort and acid reflux discomfort continues.
didn't feel well/feels off; arm was sore; shaking; heart racing; chills; 99.8 degree temperature; body aching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (didn't feel well/feels off), PAIN IN EXTREMITY (arm was sore), TREMOR (shaking), PALPITATIONS (heart racing) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 03M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter. No concomitant medication reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (didn't feel well/feels off), PAIN IN EXTREMITY (arm was sore), TREMOR (shaking), PALPITATIONS (heart racing), CHILLS (chills), PYREXIA (99.8 degree temperature) and MYALGIA (body aching). At the time of the report, VACCINATION COMPLICATION (didn't feel well/feels off), PAIN IN EXTREMITY (arm was sore), TREMOR (shaking), PALPITATIONS (heart racing), CHILLS (chills), PYREXIA (99.8 degree temperature) and MYALGIA (body aching) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 99.8 degree (High) 99.8 Degree Temperature.
Two weeks to the day after having second injection of Pfizer Vaccine a lump began to grow behind my right nipple inside my chest/breast.  The lump is very painful when pressed on and is shaped like a Cylinder closely resembling a small tootsie roll.  The length is approximately 2 inches long and the diameter is maybe 1/4 an inch.
I woke up with shortness of breath. I used my inhaler but it had absolutely no effect on the heavy breathing or wheezing. These systems lasted four hours. I stayed at home to wait it out, but if it had gotten even a little bit worse I would have headed to the ER.
Bad joint and muscle pain in my left leg; Bad joint and muscle pain in my left leg; poking me with the pin on my chin and my left chin also.; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: unknown and expiration date: not reported), via an unspecified route of administration, on 27Mar2021, as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 30Mar2021, 3 days after the vaccination, the patient experienced bad joint and muscle pain in left leg, patient had got like someone is poking patient with the pin on chin and left chin also. The patient would like to know if that was normal. The outcome of the events was unknown at time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
One of our technicians was administering a Covid vaccine to a patient and as soon as she injected the patients arm, the patient developed a quarter sized raised red bump on her arm. The patient was with her caregiver who was an R.N. and we watched the patient for about 20 minutes. Over that time the bump did decrease in size by about 75% and the patient stated that she felt fine and had had some local reactions in the past, but not that big. I continued to watch her for a few more minutes and there was no further change in size or appearance but since she was with her caregiver, I allowed her to leave. I made sure that they both understood to call 911 if anything more severe started to occur and they agreed.
Patient having arm pain along with back pain on the same side as the vaccine site.  She also reports shooting pains in her fingers on her left hand as well.
Information has been received from a registered nurse referring to a 13 month old male patient. There were no pertinent medical history or drug reactions/allergies. On 14-JAN-2016 the patient was vaccinated with a dose of VARIVAX (Merck) (lot # L024252, expiration date: 30-JUN-017, dose 1, subcutaneous). Other suspect therapies included M-M-R II (dose 1, dose, lot#, expiration and route not reported) on 14-JAN-2016. There was no concomitant medication. It was reported that the patient developed a widespread rash on 07-FEB-2016. The patient was evaluated by an unspecified physician assistant on 08-FEB-2016 and was diagnosed with chickenpox. No treatment was recommended. There was no lab diagnostics studies performed. The causality was not reported. This is one of two reports from the same reporter. Additional information has been requested.
One week after vaccination. Saw redness rash like near the injection site. Swelling and warm to the touch.
Injection site warm to touch. Length of bicep is red and slightly swollen. Possibly spreading down arm. Patient went to doctors office and got out-patient treatment of doxycycline and prednisone.
Headache, Sedation, Myalgia, Fever, NauseaVomiting, fatigue and pain at the injection site.
PNEUMOVAX and FLUZONE HD was administered and patient is complaining of redness and itching on arm.
Bell's palsy on left side of face. Anxiety/panic attacks and depressive feelings also before the bell's palsy arose.
Patient developed small red itchy bumps: 2 on her thumb, 2 on her inner arm, 4 on her ring finger, and 2 above her eyebrow, 1 and 1/2 weeks after receiving ZOSTAVAX. She said these bumps were not blistered and reminded her of when she had chickenpox as a child. She called the pharmacy to ask if a person could develop chickenpox from the shingles vaccine. I called the Merck consultant and they said that there was nothing in their files that spoke of this as a possibility. They are sending this to the global medical unit and will be contacting me back with any further information. I informed the patient to check with her doctor to see if they think that this is chickenpox also.
Patient received first COVID vaccination dose without any allergic reaction. However, due to patient's nut and penicillin allergy she met criteria for a 30 minute observation period following both doses. With her 2nd COVID dose, no allergic symptoms developed within the 30 minutes observation period and she was released from the clinic. After leaving the vaccination clinic she presented to the Emergency Department with rash/flushing of her face and developing hives. She was not short of breath and was not developing throat tightness but she was given 1 dose of epinephrine 0.3 mg intramuscular. Her allergy symptoms quickly resolved.
Patient is an 88M  with h/o CAD, A-Fib on chronic Eliquis, HTN, HLD, NIDDM, CKD, seizure disorder on chronic AED, chronic anemia, GERD, gout and OSA, who presents today with generalized weakness and progressive inability to attend to ADL's.  He lives at home with his spouse, who was recently diagnosed with COVID.  He has symptoms of  fatigue, intermittent subjective fever and chills, appetite change, dry cough, myalgias/arthralgias and lightheadedness.   In the ER, he was afebrile, hypertensive, tachycardic and tachypneic, saturating normally on baseline 2L via NC.  CXR shows no acute processes with mention of moderate sized HH.  EKG shows rate-controlled A-Fib with non-specific ST changes, but no e/o ACS. COVID PCR +   He received monoclonal antibody 10/22 and was started on decadron 6 mg daily for persistent fevers.  His fevers resolved.  He was weaned to home O2 requirement.  He was medically stable for discharge.   PT/OT recommends SAR
Pt received both doses of the Pfizer COVID vaccine (on 1/26/2021 and 2/16/2021).  On  8/16/2021, she tested positive for COVID 19 via PCR. Notes: " She then presented to care on 8/16 with cough, congestion, and fever.  Patient was found to be COVID-19 positive.  Patient was hemodynamically stable, and safe for discharge home.  Patient was immunized in February of this year with Pfizer vaccine.  Patient reports she has not been eating and drinking well because she has had "no appetite.  She reports a dry cough and some congestion.  She has had "a little" diarrhea.  She states she has been urinating normally.  She has had no evidence of black or tarry stools.  She reports no chest pain or pressure."  She had 2 unresponsive episodes on 8/21/2020 and was admitted to the hospital.  Provider notes: "Patient is at risk secondary to her immune compromised status for not having robust immune response to the vaccine"  "acute metabolic encephalopathy-worsening daily +c.dif, + COVID 8/16/21 despite vaccine status -witnessed x 2 8/23 and 8/24, 2/2 narcotics, did improve with narcan -more sick than usually see with c.dif alone -pt also tested + covid, suspect more susp given cardiorenal failure and chronic pred use -will hold bumex given persistent diarrhea with hypokalemia -electrolyte abnl-stable, noted anion gap but pt is ESRD on PD with persistent gap noted -noted dx c.dif and covid, possible two infections together could cause degree of encephalopathy -not safe to return home,not safe to discharge period -placed palliative care consult and asked for a family meeting tomorrow"
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 27Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 47 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 25Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: FLOVENT, start date: Jan2018, stop date: 15Jul2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: newly positive with return of symptoms. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: No known allergies. The patient received Paxlovid from 04Jul2022 to 08Jul2022 for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.